Skip to content

THC-O-Acetate: Scarce Evidence for a Psychedelic Cannabinoid.

Daniel J Kruger, Carlton Cb Bone, Meredith C Meacham, Charles Klein, Jessica S Kruger

Journal of psychoactive drugs January 1, 2024 DOI: 10.1080/02791072.2023.2230573 via PubMed

Summary

AI-generated from the abstract

A survey of THC-O-acetate users found that the semi-synthetic cannabinoid produces low to moderate cognitive distortions—altered sense of time, concentration difficulties, and short-term memory problems—with few visuals or hallucinations. Scores on the Mystical Experience Questionnaire were significantly below the threshold for a complete mystical experience across all four dimensions. Users who had previously used classic psychedelics (5-HT2A agonists) scored lower on all dimensions. When asked directly, 79% of respondents said using THC-O-acetate is "not at all" or "a little" of a psychedelic experience. Some reports of psychedelic effects may stem from expectations or contaminants.

Study at a glance

Characteristics Cross-sectional survey Peer reviewed
Population THC-O-acetate consumers recruited through an online forum
Topics Cannabis
Keywords Cannabinoid Psychedelic THC-O-Acetate Thco
Citations 9
Key finding THC-O-acetate produces low to moderate cognitive distortions but does not induce a psychedelic or mystical experience comparable to classic psychedelics.

Abstract

There is a growing interest in semi-synthetic cannabinoids, including THC-O-acetate (THC-Oac). Some cannabis marketers and users have claimed that THC-Oac produces psychedelic effects; the current study is the first to examine this claim. Researchers developed an online survey for THC-Oac consumers based on previous cannabis and psychedelic use surveys and in consultation with the moderator of an online forum. The survey assessed the experiential profile of THC-Oac and included items from the Mystical Experience Questionnaire (MEQ), an instrument for assessing psychedelic experiences. Participants reported a low to moderate level of cognitive distortions (altered sense of time, difficulties concentrating, difficulties with short-term memory) and few visuals or hallucinations. Participants' responses were significantly below the threshold for a complete mystical experience on all four MEQ dimensions. Participants who had used classic (5-HT2A agonist) psychedelics had lower scores on all MEQ dimensions. When asked directly, 79% responded that using THC-Oac is "not at all" or "a little" of a psychedelic experience. Some reports of psychedelic experiences may be due to expectations or contaminants. Those having prior experience with classic psychedelics had lower ratings of mystical experiences.

Explore topics

Comments

No comments yet.

Log in to comment